Marksans Pharma - Quaterly Results

14 Nov 2022 Evaluate
The total revenue for the quarter ended September 2022 remained nearly unchanged at Rs. 1702.59 millions.Net Profit recorded in the quarter ended September 2022 rise to 45.77% to Rs. 402.29  millions  compared to R. 275.97 millions in corresponding previous quarter.Operating profit surged to 548.05 millions from the corresponding previous quarter of 425.27 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1702.59 1688.53 0.83 3294.11 3160.74 4.22 6582.89 5995.48 9.80
Other Income 210.34 85.98 144.64 404.66 225.38 79.55 422.51 311.56 35.61
PBIDT 548.05 425.27 28.87 858.44 815.64 5.25 1559.66 1448.68 7.66
Interest 12.91 12.02 7.40 21.08 18.32 15.07 37.95 53.45 -29.00
PBDT 535.14 413.25 29.50 837.36 797.32 5.02 1521.71 1395.23 9.07
Depreciation 45.30 43.04 5.25 90.48 85.33 6.04 176.63 151.93 16.26
PBT 489.84 370.21 32.31 746.88 711.99 4.90 1345.08 1243.30 8.19
TAX 87.55 94.24 -7.10 152.53 146.96 3.79 305.20 259.49 17.62
Deferred Tax 1.88 18.60 -89.89 0.94 15.08 -93.77 5.04 -22.39 -122.51
PAT 402.29 275.97 45.77 594.35 565.03 5.19 1039.88 983.81 5.70
Equity 404.23 409.31 -1.24 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 32.19 25.19 27.81 26.06 25.81 0.99 23.69 24.16 -1.95

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×